echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The next round of national mining: spine "wait more", trauma "take first"?

    The next round of national mining: spine "wait more", trauma "take first"?

    • Last Update: 2021-12-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The next stop of the country has been decided? Trauma is on the battlefield first.
    After the coal mining dust is settled, who will be on the battlefield of the country mining in the next round is the focus of the industry
    .
    Previously, it was rumored that the spine was locked into the next round of nationally sourced varieties
    .
    However, on November 12, the Tianjin Medical Purchasing Center issued a document "Notice on Carrying out Centralized Maintenance of Orthopedic Trauma Medical Consumables Information", which may indicate a change in the nationally sourced varieties
    .
    The content of the document shows that orthopedic trauma will start the centralized maintenance of orthopedic trauma medical consumables information from November 17
    .
    The range of varieties includes bone plates and supporting screws, intramedullary nails and accessories, hollow screws (hollow screws) and other orthopedic trauma medical consumables
    .
    Tianjin Pharmaceutical Purchasing Center, as the lead unit of the national organization of joint procurement of high-value medical consumables, is responsible for the specific implementation of national procurement
    .
    Information maintenance is generally regarded as a prelude to centralized procurement.
    The release of this article means that the next round of national procurement is clear? Trauma will go to the battlefield of Guocai before the spine? The information maintenance work schedule is from November 17th to November 26th
    .
    Whether orthopedic trauma will be used as the third round of nationally collected species, it will be announced after the release of follow-up documents
    .
    Trauma is “mined in a small country”, with an average decrease of 88.
    65%.
    Trauma, as one of the four major branches of orthopedics, has a huge amount of consumables, mature clinical use, more than 100 manufacturers, full competition, and domestic products have a market share of nearly 90%, regardless of market size It is still the technical process, and the wounds are already equipped with the conditions for centralized procurement
    .
    In this context, the Henan Twelve Provinces Union launched the traumatic "small country mining" in July this year
    .
    The 12 provinces covered this time have a population of approximately 550 million people, accounting for about 40% of the country's total population, and accounting for one third of the market share of trauma and orthopedic consumables
    .
    For Guocai, there is a strong sample significance
    .
    20,751 products from 71 companies in Henan’s Twelve Provinces Union Central Procurement are planned to be selected, an average drop of 88.
    65%
    .
    The lowest proposed selection price of ordinary bone plate system was 280.
    54 yuan, and the highest proposed selection price was 821.
    86.
    The price dropped from an average price of about 4683 yuan to about 606 yuan, a decrease of 87.
    05%; locked (universal) compression bone plate system, the lowest proposed selection price was 481.
    59 Intramedullary nail system, the lowest proposed selection price was 583.
    68 yuan, the highest proposed selection price was 1,495.
    33 yuan, and the average price was 11,687 yuan.
    The price dropped to around 1271 yuan, a decrease of 89.
    12%; the price of a femoral intramedullary nail (titanium alloy) of the intramedullary nail system dropped from the original 11,687.
    24 yuan to 583.
    68 yuan, a decrease of 95.
    01%
    .
    The twelve provinces "group together" and jointly cut the "fracture price"
    .
    Although from the perspective of national procurement policies, the decline in centralized procurement is milder than expected, and the Medical Insurance Bureau is gradually focusing on guiding reasonable price cuts
    .
    But once it enters the country, facing a larger market, trauma prices will surely usher in a violent price reduction storm
    .
    For orthopedics practitioners, it is still a battle of life and death
    .
    Under the predicament of the prisoners of centralized procurement, competing for the emerging track.
    In the context of centralized procurement, companies with core innovation capabilities have increasingly highlighted their competitiveness in the market
    .
    Some emerging tracks that represent future development directions have also become the focus of corporate layout, such as biodegradable materials
    .
    With orthopedic trauma bone plates, the main raw materials currently produced are Nitinol, stainless steel, titanium, etc.
    , of which stainless steel is the most used, accounting for 42%
    .
    With the rapid development of modern medical technology, degradable materials are also used in bone plates
    .
    Degradable materials have good compatibility with human tissues, can be absorbed by the human body or completely discharged from the body after being degraded in the human body, will not accumulate in the internal tissues or organs of the human body, and have strong stability and ease of processing Sex, the market has great potential for development
    .
    Among them, polylactic acid (PLA) is a degradable material widely used in biomedicine.
    Due to its good relatively long-term mechanical properties in the human body, it becomes a load-bearing material such as orthopedic fixation
    .
    At present, a variety of orthopedic products have been developed based on PLA, such as soft tissue fixation screws and phantom suture anchors
    .
    However, domestically produced raw materials are currently highly dependent on overseas imports.
    Most domestic production companies have relatively low technological innovation capabilities, and high-precision materials are mainly imported
    .
    Domestic manufacturers have weak bargaining power, and production costs are easily affected by raw material suppliers and fluctuate, which limits the progress of product development and production
    .
    With the advancement of centralized procurement and the acceleration of industry innovation, domestic orthopedic products are gradually shifting to high-end links.
    In the future, innovative orthopedic materials such as biodegradable materials will also usher in rapid development
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.